WHO ICTRP trial
An Observational Study of Faricimab Treatment for Diabetic Macular Edema…
JPRN-UMIN000057639 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000057639 |
|---|---|
| Public title | An Observational Study of Faricimab Treatment for Diabetic Macular Edema, Age-related Macular Degeneration, and Retinal Vein Occlusion |
| Scientific title | An Observational Study on the Efficacy and Safety of Faricimab for Diabetic Macular Edema, Age-related Macular Degeneration, and Retinal Vein Occlusion - FARICIMAB-RO (Observational) |
| Primary sponsor | Yokohama City University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Diabetic Macular Edema, Age-related Macular Degeneration, and Macular Edema Secondary to Retinal Vein Occlusion |
| Registration date | Apr 17, 2025 |
| Target size | 500 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: